<DOC>
	<DOCNO>NCT01238315</DOCNO>
	<brief_summary>The purpose Phase Ib study determine `` Human Central Nervous System Stem Cells '' ( HuCNS-SC ) safe transplant subject infantile late infantile neuronal ceroid lipofuscinosis . The study also measure post-transplantation disease progression .</brief_summary>
	<brief_title>Safety Efficacy Study HuCNS-SC Subjects With Neuronal Ceroid Lipofuscinosis</brief_title>
	<detailed_description>Participation study involve screen assessment , surgery implant HuCNS-SC , medication suppress immune system series follow-up assessment .</detailed_description>
	<mesh_term>Neuronal Ceroid-Lipofuscinoses</mesh_term>
	<criteria>Age 6 month 6 year Male female Clinical diagnosis Infantile neuronal ceroid lipofuscinosis late infantile neuronal ceroid lipofuscinosis CLN1 CLN2 mutation Previously receive organ , tissue bone marrow transplantation Previously participate gene cell therapy study Infection hepatitis virus , cytomegalovirus , EpsteinBarr virus , Human Immunodeficiency Virus ( HIV ) Current prior cancer Bleeding disorder Unable MRI scan</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Batten 's disease</keyword>
	<keyword>INCL</keyword>
	<keyword>LINCL</keyword>
	<keyword>Neuronal Ceroid Lipofuscinosis</keyword>
	<keyword>NCL</keyword>
</DOC>